Biomarker | Dylan Neel | Substack

RA Capital: Rajeev Shah

"The ideal investors find a balance."

Nov 13 •

and

New

Top

Community

Lab Meeting: Jim Collins

"Can we build something from the bottom up? Can we put circuits together with genes?"

Oct 31 •

and

Novo Nordisk: Uli Stilz

“As scientists, we can make a real impact. I wouldn't want to do anything else with my life.”

Oct 24 •

and

Enveda Bio: Viswa Colluru

"Smart, ambitious people like working on hard things."

Oct 17 •

Tessera: Jacob Rubens

“If you can imagine a better solution than the one you're working on, you're probably focusing on the wrong solution.”

Oct 3 •

and

Lab Meeting: Ira Mellman

“In immunology there is enormous opportunity for mechanistic science to help human health.”

Sep 26 •

Lime Tx: Shardule Shah (CEO) and Prakrit Jena (CTO)

"We are so excited about the potential of what we can discover."

Aug 16 •

Scribe Therapeutics: Ben Oakes

Listen now | brought to you by Nucleate Signal

Aug 10 •

48:49

Biomarker

Biomarker

Interviews with scientists, physicians, industry experts and investors.

Recommendations

Transition States

Nick Edwards, PhD

BIOS

Biomarker

About Archive Recommendations Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts